El-Damasy, A.K.; Kim, H.J.; Al-Karmalawy, A.A.; Alnajjar, R.; Khalifa, M.M.; Bang, E.-K.; Keum, G.
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals 2024, 17, 427.
https://doi.org/10.3390/ph17040427
AMA Style
El-Damasy AK, Kim HJ, Al-Karmalawy AA, Alnajjar R, Khalifa MM, Bang E-K, Keum G.
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals. 2024; 17(4):427.
https://doi.org/10.3390/ph17040427
Chicago/Turabian Style
El-Damasy, Ashraf K., Hyun Ji Kim, Ahmed A. Al-Karmalawy, Radwan Alnajjar, Mohamed M. Khalifa, Eun-Kyoung Bang, and Gyochang Keum.
2024. "Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies" Pharmaceuticals 17, no. 4: 427.
https://doi.org/10.3390/ph17040427
APA Style
El-Damasy, A. K., Kim, H. J., Al-Karmalawy, A. A., Alnajjar, R., Khalifa, M. M., Bang, E. -K., & Keum, G.
(2024). Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals, 17(4), 427.
https://doi.org/10.3390/ph17040427
